Predicting long-term pain after head and neck radiotherapy
Part of Brain & nervous system, Cancer, Mental health, Pain clinical trials.
This study looks for ways to predict and improve pain you may have months after radiotherapy for first head and neck cancer. It may help doctors better anticipate pain and support patients during recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a first (new) head and neck cancer that will be treated with radiotherapy.
- You have never had radiotherapy before.
- Your cancer has not come back or progressed at the time you are checked for the study.
- You expect to live more than 3 months.
- You can read and speak French well enough to do study visits and questionnaires.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at why some people with cancer develop nerve pain (neuropathic pain) during treatment. By tracking your health and symptoms, researchers hope to find ways to predict and prevent this side effect.
This trial tests a drug called Crisugabalin to see if it helps people with nerve pain caused by radiation treatment for head and neck cancer. The study aims to find a better way to manage this type of pain that does not go away.
This study looks at whether certain imaging tests (like MRI, CT, and PET scans) can predict how well your head and neck cancer responds to a standard treatment of radiation plus the chemotherapy drug cisplatin. If you join, researchers will use your scans and treatment results to help personalize care for future patients.
This study looks at whether mild memory or thinking issues after breast cancer treatment are linked to ongoing pain. If you join, you will help doctors understand this connection, which may lead to better pain care.
This study looks at immune system signals in your blood during and after postoperative radiation therapy for certain head and neck cancers involving the brain or skull base. Researchers want to see whether these “immune markers” relate to treatment response or side effects.
This study looks at nerve-related symptoms and pain in the mouth and throat in people who have been treated for oral or oropharynx cancer. You may be able to take part if you’re within 1 to 5 years after treatment and can follow study steps.
Hear when a new Neuropathic Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.